Opens in a new tab

Breaking news

Why the UAE Is Becoming A Premier Destination For Medical Tourism

With a commitment to enhancing its healthcare offerings, the UAE has positioned itself as a leader in medical tourism, catering to a growing global demand. As countries focus on improving the health of their populations, the UAE stands out for its strategic investments in both healthcare infrastructure and its appeal to medical tourists.

According to Statista, the global medical tourism market was valued at $47 billion in 2024, with projections indicating it could exceed $111 billion by 2029. The UAE is setting the bar high, with innovative initiatives such as specialized portals for health tourists and streamlined entry processes for medical visitors.

Tailored Portals And Seamless Experiences

Abu Dhabi and Dubai have launched dedicated online platforms that streamline the process for medical tourists. These portals offer a range of services, including healthcare provider contact information, appointment bookings, hotel reservations, and local transportation. Dubai Health Authority (DHA) introduced the Dubai Health Experience (DXH) brand in 2016, aimed at making the city a global leader in health tourism. The platform offers a curated selection of top-tier treatments in fields such as dentistry, fertility, ophthalmology, and cosmetic surgery.

Meanwhile, in 2018, Abu Dhabi’s Department of Health (DoH) rolled out its own e-portal, showcasing a network of over 40 healthcare facilities that meet the stringent quality standards of the DoH’s JAWDA program. Visitors can explore nearly 300 treatment packages across specialties ranging from routine check-ups to complex surgeries.

Simplified Access With Specialized Permits

To further attract international patients, the UAE offers specialized entry permits for medical tourists and their companions. These permits, which can be single or multiple entries, are sponsored by medical institutions and processed by relevant authorities in the country. Dubai Healthcare City also introduced a new medical visa in January 2024, allowing treatment centers to apply for permits on behalf of patients for stays of up to six months. This move bolsters Dubai’s reputation as a medical tourism hotspot.

The city welcomed 674,000 medical tourists in 2022, generating $270 million in revenue. Wellness tourism is also booming in the UAE, with visitors spending $5.4 billion in 2022—almost double the amount spent in 2020.

Innovation At The Forefront

The UAE’s innovative spirit continues to propel its rise as a medical tourism hub. In 2024, HealthStay.io, the world’s first AI-powered medical tourism solution, launched in partnership with Dubai Health Experience. This startup, part of the Mohammed Bin Rashid Innovation Fund’s Accelerator Program, uses artificial intelligence to automate the medical tourism journey, including selecting treatments and booking appointments.

“The launch of HealthStay.io is a direct result of the support from DXH and DHA, helping us transform Dubai into a global healthcare tourism leader,” said Ruairi Tubrid, co-founder of HealthStay.io. Fatima Yousif Alnaqbi, MBRIF representative, emphasized the importance of accelerator programs in supporting innovative solutions that elevate the UAE’s standing as a center of excellence in healthcare.

Government Commitment To Healthcare Excellence

The UAE’s rapid growth in medical tourism is rooted in its consistent focus on healthcare improvement. Key strategies such as the Emirates Health Services Innovation Strategy 2023-2026 and the National Strategy for Wellbeing 2031 aim to enhance residents’ quality of life and elevate the nation’s healthcare offerings.

Compared to its Gulf Cooperation Council (GCC) counterparts, the UAE leads in healthcare expenditure growth. Projections from Alpen Capital estimate that healthcare spending will reach $30.7 billion by 2027, reflecting the nation’s ongoing dedication to strengthening its healthcare infrastructure. As a result, the UAE continues to attract international patients seeking top-tier medical services.

Cyprus Government Surplus Rises To €1.61 Billion In First Nine Months Of 2026

Cyprus recorded a general government surplus of €1.61 billion in the first nine months of 2026, equal to 4.0% of gross domestic product, as revenue growth outpaced the rise in public spending. Higher receipts from income taxes, social contributions and value-added tax (VAT) drove the improvement, while lower capital expenditure helped restrain spending.

Preliminary figures released Tuesday by the Statistical Service of Cyprus show the surplus rose to €1.17 billion, or 3.0% of GDP, up from € 442.1 million in the same period of 2025.

Total government revenue increased 6.5% to €12.09 billion, while expenditure rose 2.9% to €10.48 billion.

Key Fiscal MeasureJanuary–September 2025January–September 2026
Total revenue€11,353.9 million€12,091.8 million
Total expenditure€10,186.2 million€10,482.1 million
Government surplus€1,167.6 million€1,609.7 million
Surplus as a share of GDP3.0%4.0%

Income Taxes And VAT Lead Revenue Growth

Taxes on income and wealth made the largest contribution to the increase in revenue. Receipts in this category climbed by €442.2 million, or 15.3%, to €3.34 billion, compared with €2.89 billion a year earlier.

Social contributions rose by €235 million, or 6.6%, to €3.78 billion. Taxes on production and imports increased by €251.5 million, or 7.2%, reaching €3.77 billion.

Net VAT receipts, after refunds, totalled €2.64 billion, up €293.1 million, or 12.5%, from €2.35 billion in the first nine months of 2025.

Some Revenue Streams Decline

Not all revenue categories moved higher. Capital transfers fell by €74.6 million to €96.7 million, while current transfers declined by €71.6 million, or 20.5%, to €278.2 million.

Revenue from services slipped 1.0% to €743.5 million. Interest and dividend receipts dropped by €37 million, or 28.6%, to €92.4 million.

Social Benefits And Personnel Costs Increase

On the expenditure side, social benefits rose by €199.6 million, or 4.9%, to €4.27 billion. Compensation of employees—which includes imputed social contributions and public-sector pensions—increased by €108.3 million, or 3.8%, to €2.99 billion.

Intermediate consumption, covering goods and services used in the delivery of public services, rose by €114.3 million, or 11.0%, to €1.16 billion. Interest payments increased by €8.7 million, or 2.6%, to €340.7 million. Current transfers were up €68.7 million, or 10.6%, at €714.7 million.

Lower Capital Spending Limits Expenditure Growth

The overall increase in spending was tempered by a decline in capital expenditure. Capital-account spending fell by €189.9 million, or 16.9%, to €936.2 million from €1.13 billion in the same period last year.

Investment in fixed capital declined by €94.1 million, or 12.1%, to €686.4 million. Other capital transfers fell by €95.8 million, or 27.7%, to €249.8 million. Subsidies also decreased, dropping by €13.9 million, or 15.5%, to €75.8 million.

eCredo
Uol
The Future Forbes Realty Global Properties
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter